{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01351610",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MSC_Apceth_001"
      },
      "Organization": {
        "OrgFullName": "Apceth GmbH & Co. KG",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia",
      "OfficialTitle": "Open, Randomized, Mono-Centre, Two-Parallel Group Clinical Phase I/II Trial on the Evaluation of Tolerability and Efficacy of an Intravenous Infusion of Human Bone Marrow Derived Autologous, CD34-Negative Mesenchymal Stem Cells for the Treatment of Critical Limb Ischemia in Patients With Advanced Peripheral Arterial Occlusive Disease Subsequent to Percutaneous Transluminal Angioplasty"
    },
    "StatusModule": {
      "StatusVerifiedDate": "December 2015",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "March 2011"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "October 2014",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "October 2015",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "May 10, 2011",
      "StudyFirstSubmitQCDate": "May 10, 2011",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "May 11, 2011",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "December 14, 2015",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "December 15, 2015",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Apceth GmbH & Co. KG",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "MSC_Apceth are GMP-manufactured, autologous ex-vivo expanded non-hemapoietic bone-marrow derived stem cells for the treatment of Critical Limb Ischemia"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Critical Limb Ischemia",
          "Peripheral Artery Disease"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Critical Limb Ischemia",
          "Peripheral Arterial Occlusive Disease",
          "Peripheral Artery Disease",
          "Peripheral Vascular Disease",
          "Stem Cell Therapy",
          "Mesenchymal Stem Cells"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "25",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Group B",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: PTA"
              ]
            }
          },
          {
            "ArmGroupLabel": "Group A",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: PTA + Infusion of MSC_Apceth"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "PTA + Infusion of MSC_Apceth",
            "InterventionDescription": "percutaneous transluminal angioplasty followed by infusion of MSC_Apceth",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Group A"
              ]
            }
          },
          {
            "InterventionType": "Procedure",
            "InterventionName": "PTA",
            "InterventionDescription": "percutaneous transluminal angioplasty only",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Group B"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Collection of adverse events",
            "PrimaryOutcomeTimeFrame": "one year"
          },
          {
            "PrimaryOutcomeMeasure": "Safety laboratory values",
            "PrimaryOutcomeTimeFrame": "1 year"
          },
          {
            "PrimaryOutcomeMeasure": "ECG findings",
            "PrimaryOutcomeTimeFrame": "1 year"
          },
          {
            "PrimaryOutcomeMeasure": "Analysis of inflammation markers",
            "PrimaryOutcomeTimeFrame": "1 year"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Comparison of course of haemodynamic and vascular processes",
            "SecondaryOutcomeTimeFrame": "1 year"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with peripheral arterial occlusive disease (symptomatic PAOD), diagnosis of CLI defined as persistent, recurring ischemic rest pain for at least 2 weeks, and/or ulceration or gangrene of the foot or toe, with an ABPI </= 0.5,\nPatients with staging of ≥III according to Fontaine and ≥4 according to Rutherford categories,\nPatients fulfilling the criteria for an invasive re-vascularisation procedure (PTA) at the discretion of the investigator,\nPatients without major amputation of the lower extremities within the period of 6 months after inclusion in the opinion of the investigator,\n\nExclusion Criteria:\n\nPatients with wounds of a severity of greater than grade 2 on the Wagner Scale,\nPatients with life-threatening ventricular arrhythmia,\nPatients with unstable angina pectoris,\nPatients with severe congestive heart failure (i.e. NYHA Stage IV),\nPatients with uncontrolled hypertension (defined as diastolic blood pressure >110 mmHg or systolic blood pressure >180 mmHg during screening),\nPatients with an uncontrolled diabetes mellitus (HbA1c > 9%),\nPatients having any history of malignant tumour in the anamnesis or are currently on tumour treatment,\nPatients who are unsuitable for a MSC stem cell therapy in the opinion of the investigator,",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "40 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Peter Heider, MD, PhD",
            "OverallOfficialAffiliation": "Isar Medizin Zentrum, München",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Isar Medizin Zentrum",
            "LocationCity": "Munich",
            "LocationState": "Bavaria",
            "LocationZip": "80331",
            "LocationCountry": "Germany"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000058729",
            "ConditionMeshTerm": "Peripheral Arterial Disease"
          },
          {
            "ConditionMeshId": "D000001157",
            "ConditionMeshTerm": "Arterial Occlusive Diseases"
          },
          {
            "ConditionMeshId": "D000007511",
            "ConditionMeshTerm": "Ischemia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000050197",
            "ConditionAncestorTerm": "Atherosclerosis"
          },
          {
            "ConditionAncestorId": "D000001161",
            "ConditionAncestorTerm": "Arteriosclerosis"
          },
          {
            "ConditionAncestorId": "D000014652",
            "ConditionAncestorTerm": "Vascular Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          },
          {
            "ConditionAncestorId": "D000016491",
            "ConditionAncestorTerm": "Peripheral Vascular Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M28366",
            "ConditionBrowseLeafName": "Peripheral Arterial Disease",
            "ConditionBrowseLeafAsFound": "Peripheral Artery Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18046",
            "ConditionBrowseLeafName": "Peripheral Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3617",
            "ConditionBrowseLeafName": "Arterial Occlusive Diseases",
            "ConditionBrowseLeafAsFound": "Arterial Occlusive Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M25341",
            "ConditionBrowseLeafName": "Atherosclerosis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3621",
            "ConditionBrowseLeafName": "Arteriosclerosis",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}